DARE - Daré Bioscience, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 513.38M
Enterprise Value 39.98M
Trailing P/E N/A
Forward P/E 1-0.99
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.42
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 2.40
52-Week Change 3-44.06%
S&P500 52-Week Change 37.70%
52 Week High 33.2500
52 Week Low 30.6000
50-Day Moving Average 30.8509
200-Day Moving Average 30.9620

Share Statistics

Avg Vol (3 month) 3371.25k
Avg Vol (10 day) 359.83k
Shares Outstanding 5N/A
Float 13.93M
% Held by Insiders 116.92%
% Held by Institutions 18.11%
Shares Short (Jun 28, 2019) 4730.08k
Short Ratio (Jun 28, 2019) 41.37
Short % of Float (Jun 28, 2019) 45.24%
Short % of Shares Outstanding (Jun 28, 2019) 44.38%
Shares Short (prior month May 31, 2019) 4523.55k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Jul 20, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-70.95%
Return on Equity (ttm)-123.72%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-625k
EBITDA N/A
Net Income Avi to Common (ttm)-12.13M
Diluted EPS (ttm)-1.0620
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.51M
Total Cash Per Share (mrq)0.21
Total Debt (mrq)139.29k
Total Debt/Equity (mrq)3.68
Current Ratio (mrq)4.19
Book Value Per Share (mrq)0.33

Cash Flow Statement

Operating Cash Flow (ttm)-11.46M
Levered Free Cash Flow (ttm)-8.19M